Osmolality monitoring for UF/DF and CEX capture of mAbs from mammalian cell cultures
12 July 2022

Biopharmaceutical manufacturing of biologic entities, such as monoclonal antibodies (mAb), vaccines, and other protein species requires a specific and, at times, complex set of operational steps. This application note compares methods for osmolality monitoring from mammalian cell cultures.